Acute Conjunctivitis Anxiety Dissociative and Somatoform Disorders Atrial Fibrillation and Atrial Flutter Bronchial Asthma Chronic Renal Disease
Languages:
English Spanish
Description:
Dr. Lockhart graduated from the Indiana University School of Medicine in 1976. He works in Quincy, IL and specializes in Family Medicine. Dr. Lockhart is affiliated with Blessing Hospital.
Us Patents
Identification Of Molecular Sequence Signatures And Methods Involving The Same
David J. Lockhart - Del Mar CA Gordon G. Wong - Brookline MA
Assignee:
Affymetrix, Inc. - Santa Clara CA
International Classification:
C12Q 168
US Classification:
435 6, 536 231, 536 243, 935 76, 935 77, 935 78
Abstract:
Novel means and methods for analyzing hybridization data derived from hybridization assays between a target nucleic acid and differently sequenced polynucleotide probes involve selecting probe sets that define reference sequences for sequence signatures and deriving useful data about the nature of the target nucleic acid molecule based on its hybridization to the probes. The methods are useful for determining whether the target contains a nucleic acid or polypeptide sequence signature, whether the target encodes a member of a gene family, or whether the target is derived from one of any number of genes.
The cellular effects of potentially therapeutic compounds are characterized in mammalian cells and yeast. In the latter case the effects can be characterized on a genome-wide scale by monitoring changes in messenger RNA levels in treated cells with high-density oligonucleotide probe arrays.
A method is described for determining the genotype of one or more individuals at a biallelic marker. The method employs amplification of a region of genomic DNA using color tagged, allele-specific primers and hybridization of the products to an array of allele-specific probes. The genotype is identified from the pattern of hybridization.
Expression Monitoring By Hybridization To High Density Oligonucleotide Arrays
David J. Lockhart - Del Mar CA, US Eugene L. Brown - Newton Highlands MA, US Gordon G. Wong - Brookline MA, US Mark Chee - Palo Alto CA, US Thomas R. Gingeras - Encinitas CA, US
This invention provides methods of monitoring the expression levels of a multiplicity of genes. The methods involve hybridizing a nucleic acid sample to a high density array of oligonucleotide probes where the high density array contains oligonucleotide probes complementary to subsequences of target nucleic acids in the nucleic acid sample. In one embodiment, the method involves providing a pool of target nucleic acids comprising RNA transcripts of one or more target genes, or nucleic acids derived from the RNA transcripts, hybridizing said pool of nucleic acids to an array of oligonucleotide probes immobilized on surface, where the array comprising more than 100 different oligonucleotides and each different oligonucleotide is localized in a predetermined region of the surface, the density of the different oligonucleotides is greater than about 60 different oligonucleotides per 1 cm, and the olignucleotide probes are complementary to the RNA transcripts or nucleic acids derived from the RNA transcripts; and quantifying the hybridized nucleic acids in the array.
Uncoupling Of Dna Insert Propagation And Expression Of Protein For Phage Display
The present invention provides an advance in phage display technology by permitting the uncoupling of the propagation of phages containing inserted sequences encoding heterologous polypeptides from the expression of said polypeptides. The invention provides phage constructs and methods for their use to permit phage coat protein expression, and thus phage propagation, in the absence of display of heterologous polypeptides, which may be expressed as a fusion with said coat protein in a regulated manner.
Identification Of Molecular Sequence Signatures And Methods Involving The Same
David J. Lockhart - Del Mar CA, US Gordon G. Wong - Brookline MA, US Pennina Langer-Safer - Rehovot, IL
Assignee:
Affymetrix, Inc. - Santa Clara CA
International Classification:
C12Q 1/68 C07H 21/02 C07H 21/04
US Classification:
435 6, 536 231, 536 243
Abstract:
Novel means and methods for analyzing hybridization data derived from hybridization assays between a target nucleic acid and differently sequenced polynucleotide probes involve selecting probe sets that define reference sequences for sequence signatures and deriving useful data about the nature of the target nucleic acid molecule based on its hybridization to the probes. The methods are useful for determining whether the target contains a nucleic acid or polypeptide sequence signature, whether the target encodes a member of a gene family, or whether the target is derived from one of any number of genes.
Identification Of Molecular Sequence Signatures And Methods Involving The Same
David J. Lockhart - Del Mar CA, US Gordon G. Wong - Brookline MA, US Pennina Langer-Safer - Rehovot, IL
Assignee:
Affymetrix, Inc. - Santa Clara CA
International Classification:
C12Q 1/68 C07H 21/02 C07H 21/04
US Classification:
435 6, 536 231, 536 243
Abstract:
Novel means and methods for analyzing hybridization data derived from hybridization assays between a target nucleic acid and differently sequenced polynucleotide probes involve selecting probe sets that define reference sequences for sequence signatures and deriving useful data about the nature of the target nucleic acid molecule based on its hybridization to the probes. The methods are useful for determining whether the target contains a nucleic acid or polypeptide sequence signature, whether the target encodes a member of a gene family, or whether the target is derived from one of any number of genes.
David J. Lockhart - Del Mar CA, US Hitesh K. Patel - Encinitas CA, US Zdravko V. Milanov - San Diego CA, US Shamal Anil Mehta - San Diego CA, US Patrick Parvis Zarrinkar - San Diego CA, US Pietro Ciceri - La Jolla CA, US Miles A. Fabian - La Jolla CA, US Daniel K. Treiber - San Diego CA, US
The invention provides pyrrole-containing compounds and methods of use thereof. Kits and pharmaceutical compositions comprising the pyrrole compounds of the invention are also provided. The compounds and compositions disclosed herein are preferably used in the treatment of neurodegenerative diseases, cardiovascular diseases, proliferative diseases, and visual disorders. In particular, methods and compositions for the treatment of stroke are disclosed herein.